- Drugs
- Monday, 04 May 2020
Pharmaceutics International Selected as A Winner of Two GH&P Awards
Pharmaceutics International, Inc. (Pii), a US-based Contract Development and Manufacturing Organization (CDMO) today announced it has won the 2020 CDMO Leadership Award and was named the Most Innovative Company in Dosage Solutions by Global Health & Pharma Magazine.
"We are honored to be recognized in these two categories. Pii has an extensive range of technologies, skilled personnel and Pharmaceutics Know-How™, to enable the rapid development and reliable production of high-quality sterile and oral dosage forms. It is extremely gratifying to have our innovation, accomplishments and commitment to partners and patients acknowledged," said Dr. Kurt R. Nielsen, Pii's President and CEO.
According to GH&P, "Biotechnology is a huge, varied and ever-growing industry. Operating and succeeding in such an environment which, in many ways, demands excellence at every turn is - it goes without saying - incredibly difficult, yet there are businesses that have learned to thrive under such conditions. To harness innovation and deliver results, driving the greater industry onwards." Jazmin Collins, GH&P Awards Coordinator, commented "Regardless of their size or location, we honor companies from across this vibrant and talented sector."
Related Industry Updates
Moderna picks drugmaker Catalent to manufacture potential COVID-19 vaccine
Jun 25, 2020
Hospital Acquired Infection Treatment Market is expected to reach US$ 19,978.39 million by 2030
Dec 11, 2023
Green Valley Announces NMPA Approval Of Oligomannate For Mild To Moderate Alzheimer's Disease
Nov 04, 2019
Ionis Pharmaceuticals to present at upcoming virtual investor conferences
Jun 05, 2020
Homeopathy Market is expected to reach US$ 18,069.91 million by 2030
Aug 09, 2023
New CBD Company, InnerGreen CBD, Paves the Way for Science-Based CBD
Jun 11, 2020
Myopia Treatment Market is expected to reach US$ 19,571.85 million by 2030
Jan 10, 2024